NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
NIFTY23,4060.33%
SENSEX74,3460.41%
BANKNIFTY54,1860.88%
NIFTY IT29,3845.57%
PHARMA24,0870.33%
AUTO26,0930.05%
FMCG48,1241.01%
METAL13,5350.17%
REALTY762.601.39%
ENERGY40,1970.02%
Tarsier Pharma Ltd.

Tarsier Pharma Ltd.

TARXNYSEAMERICAN
filed

Sector

Healthcare

Filed

Apr 21, 2026

About

Tarsier Pharma Ltd.

Tarsier Pharma is a late clinical stage biopharmaceutical company, focused on the development and commercialization of novel pharmaceutical therapies to address unmet need in blinding diseases of the eye with underlying inflammatory pathologies.

Our dazdotuftide platform technology is a bio-inspired immunomodulator, designed to treat blinding inflammatory ocular diseases, and is currently being developed as both eye drops (TRS01) and intravitreal injections (TRS02).

Tarsier Pharma Ltd. Overview

Ticker, listing venue and issuer profile

TickerTARX
ExchangeNYSEAMERICAN
Statusfiled
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CIK Code2102720
CUSIP--
ISIN--

Offer & Key Dates

Pricing terms and IPO milestones

Price Range--
Offer Price--
Listing Price--
Current Price--
Shares Offered--
Shares Outstanding--
Offer Size--
Market Cap--
Filing DateApr 21, 2026
Priced Date--
Listed Date--

Financial Highlights

Historical financial performance

SEC Filings

Official documents from SEC EDGAR

Company Info

Contact and headquarters details

HeadquartersIsrael
Founded2016
Employees3
Phone+972-4-639-8050
Address10 HaMa’apilim St.Zichron Yaacov, 3093765Israel

Leadership

Key executives and officers

DH

Daphne Haim-Langford, Ph.D.

Chief Executive Officer and Chairperson of the Board

AG

Arie Ganot, CPA

Chief Financial Officer

ZM

Zohar Milman, M.Sc.

Chief Operating Officer

RN

Ron Neumann, M.D.

Chief Medical Officer

SB

Susan Benton

Director

SB

Sascha Bucher

Director

AR

Atul Raut

Director

Tarsier Pharma Ltd. IPO - FAQs

IPO (initial public offering) is the process through which a private company offers its shares to the public for the first time to raise equity capital from a broader base of public investors.

IPOScanner Logo

IPOScanner helps investors track upcoming, live and past IPOs in one place with GMP, subscription, allotment status and listing performance insights.

About IPO Scanner

IPOScanner is built for investors who want a clear view of every IPO opportunity in one place. From upcoming issues to live subscription data, allotment updates and listing performance, we bring together the key details you need to track the primary market.

Our tools are designed to be simple, fast and investor-friendly so you can focus on evaluating businesses instead of opening multiple tabs and websites for basic information.

Details of client bank account
For any query / feedback / clarifications, email at
[email protected].

Please read all offer documents and risk disclosures carefully before investing. IPOScanner does not provide investment advice and information on this site should not be treated as a recommendation to apply for any IPO.

© 2026 IPO Scanner. All rights reserved.